Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma

Background: Cancer stem cells (CSCs) play a critical role in tumor development, progression, metastasis and recurrence. Aim: To evaluate hepatic expression of CD44 and CD133 in Egyptian patients with HCV-induced chronic liver diseases and hepatocellular carcinomas (HCCs), and to assess its correl...

Full description

Bibliographic Details
Main Authors: Mohammed Saeed Rozeik, Olfat Ali Hammam, Ali Ibrahim Ali, Mona Magdy, Heba Khalil, Amgad Anas, Ahmed Abdelaleem Abo el Hassan, Ali Abdel Rahim, Ahmed Ibrahim El-Shabasy
Format: Article
Language:English
Published: Electronic Physician 2017-07-01
Series:Electronic Physician
Subjects:
hepatocellular carcinoma
Cancer stem cell
CD133
CD44
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586983/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5586983/

Similar Items